Overview

Randomized Study to Reduce Calcineurininhibitor Toxicity in Pediatric and Adolescent Kidney Transplant Recipients

Status:
Terminated
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if a safe reduction of cyclosporine A in pediatric and adolescent patients with stable renal graft function, reduces signs of calcineurin-inhibitor toxicity.
Phase:
Phase 4
Details
Lead Sponsor:
University of Erlangen-Nürnberg Medical School
Treatments:
Calcineurin Inhibitors
Cyclosporine
Cyclosporins